Adoption of a single dose of HPV vaccine in the National Immunization Schedule for females and males aged 09-14 years

Change HPV vaccine schedule from two doses to single doses for immunocompetent girls aged 10-14 years 11 months and 29 days

CTAI-HPV subgroup HPV VACCINATION MEETING IN PREPARED PERSONS: PROTOCOL AND IMPLEMENTATION Taking into account the morbidity profile of PrEP users (with increased vulnerability to sexually transmitted infections), as well as the efficacy of the vaccine in reducing lesions related to HPV genotypes, it was unanimously recommended to extend HPV vaccination to PrEP users aged 15-45 years, according to the guidelines below: